Garry Wong
Keine laufenden Positionen mehr
Profil
Garry Wong worked as a Member of the Global Mergers & Acquisitions Group at Nortel Networks Corp.
and as the Chief Financial Officer at Dragon Pharmaceutical, Inc. He also served as the Chief Financial Officer & Secretary at Cascadia Blockchain Group Corp.
from 2017 to 2019.
Mr. Wong holds an MBA from York University and an undergraduate degree from the University of Hong Kong.
Ehemalige bekannte Positionen von Garry Wong
| Unternehmen | Position | Ende |
|---|---|---|
| CASCADIA BLOCKCHAIN GROUP CORP. | Finanzdirektor/CFO | 08.10.2019 |
| NORTEL NETWORKS CORPORATION (USA) | Corporate Officer/Principal | - |
Dragon Pharmaceutical, Inc.
 Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Finanzdirektor/CFO | - |
Ausbildung von Garry Wong
| York University | Masters Business Admin |
| University of Hong Kong | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CASCADIA BLOCKCHAIN GROUP CORP. | Technology Services |
| Private Unternehmen | 2 |
|---|---|
Nortel Networks Corp.
 Nortel Networks Corp. Financial ConglomeratesFinance Nortel Networks Corp. supplies end-to-end networking products and solutions serving both service providers and enterprise customers. It designs, develops, engineers, markets, sells, supplies, licenses, installs, services, and supports networking solutions worldwide. The company was founded in 1895 and is headquartered in Mississauga, Canada. | Finance |
Dragon Pharmaceutical, Inc.
Dragon Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Dragon Pharmaceutical, Inc. produces and sells human protein therapeutics. Its products include clenbuterol, oxymetholone, dianabol and deca 300. The company was founded on August 22, 1989 and is headquartered in Vancouver, Canada. | Health Technology |
